![Carl Damiani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Carl Damiani served as the President and Chief Operating Officer of Transition Therapeutics, Inc. from 2015 to 2016.
Prior to that, he held positions at the same company from 2003 to 2016.
Former positions of Carl Damiani
| Companies | Position | End |
|---|---|---|
| TRANSITION THERAPEUTICS INC | President | 30/11/2016 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications | Commercial Services |
- Stock Market
- Insiders
- Carl Damiani
